[
    [
        {
            "time": "2022-08-07",
            "original_text": "万泰生物新冠检测盒产品获美国FDA紧急使用授权、嘉化能源董事长遭立案调查",
            "features": {
                "keywords": [
                    "万泰生物",
                    "新冠检测盒",
                    "美国FDA",
                    "紧急使用授权",
                    "嘉化能源",
                    "董事长",
                    "立案调查"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "医疗设备"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "万泰生物新冠检测盒产品获美国FDA紧急使用授权、嘉化能源董事长遭立案调查",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-07-28",
            "original_text": "万泰生物：截至7月28日公司二价宫颈癌疫苗获批签发数量为69万支",
            "features": {
                "keywords": [
                    "万泰生物",
                    "二价宫颈癌疫苗",
                    "获批签发",
                    "69万支"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "万泰生物：截至7月28日公司二价宫颈癌疫苗获批签发数量为69万支",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]